Found: 64
Select item for more details and to access through your institution.
Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study.
- Published in:
- Journal of Women's Health (15409996), 2024, v. 33, n. 4, p. 480, doi. 10.1089/jwh.2023.0037
- By:
- Publication type:
- Article
Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 14, p. 1808, doi. 10.1177/13524585231205962
- By:
- Publication type:
- Article
Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 11/12, p. 1437, doi. 10.1177/13524585231197076
- By:
- Publication type:
- Article
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 875, doi. 10.1177/13524585231151951
- By:
- Publication type:
- Article
Comparative effectiveness in multiple sclerosis: A methodological comparison.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 3, p. 326, doi. 10.1177/13524585231151394
- By:
- Publication type:
- Article
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 11, p. 1752, doi. 10.1177/13524585221084577
- By:
- Publication type:
- Article
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 842, doi. 10.1177/13524585211061335
- By:
- Publication type:
- Article
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 13, p. 2001, doi. 10.1177/13524585211047977
- By:
- Publication type:
- Article
Determinants of therapeutic lag in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 12, p. 1838, doi. 10.1177/1352458520981300
- By:
- Publication type:
- Article
The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 479, doi. 10.1177/1352458520930620
- By:
- Publication type:
- Article
Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 2, p. 220, doi. 10.1177/1352458520912379
- By:
- Publication type:
- Article
Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 1, p. 52, doi. 10.1177/1352458519901272
- By:
- Publication type:
- Article
Risk of secondary progressive multiple sclerosis: A longitudinal study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 1, p. 79, doi. 10.1177/1352458519868990
- By:
- Publication type:
- Article
Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 9, p. 1273, doi. 10.1177/1352458519841829
- By:
- Publication type:
- Article
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 541, doi. 10.1177/1352458517742739
- By:
- Publication type:
- Article
Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 14, p. 1883, doi. 10.1177/1352458517735190
- By:
- Publication type:
- Article
Multiple Sclerosis Relapses Following Cessation of Fingolimod.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 355, doi. 10.1007/s40261-022-01129-7
- By:
- Publication type:
- Article
Biofeedback Based Home Balance Training can Improve Balance but Not Gait in People with Multiple Sclerosis.
- Published in:
- Multiple Sclerosis International, 2019, p. 1, doi. 10.1155/2019/2854130
- By:
- Publication type:
- Article
Real-Life Outcome in Multiple Sclerosis in the Czech Republic.
- Published in:
- Multiple Sclerosis International, 2019, p. 1, doi. 10.1155/2019/7290285
- By:
- Publication type:
- Article
Brain MRI disease burden and sex differences in cognitive performance of patients with multiple sclerosis.
- Published in:
- Acta Neurologica Belgica, 2024, v. 124, n. 1, p. 109, doi. 10.1007/s13760-023-02350-7
- By:
- Publication type:
- Article
(DXT77) Alemtuzumab Maintains Efficacy on Clinical and Magnetic Resonance Imaging Lesion Outcomes, Including Slowing of Brain Volume Loss, Over 9 Years in Relapsing-Remitting Multiple Sclerosis Patients: CARE-MS II Follow-up (TOPAZ Study).
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 43
- By:
- Publication type:
- Article
Interpretation of Brain Volume Increase in Multiple Sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The potential of serum neurofilament as biomarker for multiple sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early clinical markers of aggressive multiple sclerosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cognitive clinico‐radiological paradox in early stages of multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 1, p. 81, doi. 10.1002/acn3.512
- By:
- Publication type:
- Article
Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00820
- By:
- Publication type:
- Article
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0300914
- By:
- Publication type:
- Article
Why patients with multiple sclerosis perceive improvement of gait during treatment with natalizumab?
- Published in:
- Journal of Neural Transmission, 2019, v. 126, n. 6, p. 731, doi. 10.1007/s00702-019-02013-z
- By:
- Publication type:
- Article
Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry.
- Published in:
- Journal of Central Nervous System Disease, 2024, p. 1, doi. 10.1177/11795735241262743
- By:
- Publication type:
- Article
Do eyes with and without optic neuritis in multiple sclerosis age equally?
- Published in:
- Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 2281, doi. 10.2147/NDT.S169638
- By:
- Publication type:
- Article
Využití krokoměrů pro zvýšení pohybové aktivity a ovlivnění chůze u pacientů s roztroušenou sklerózou, pilotní studie.
- Published in:
- Medicina Sportiva Bohemica et Slovaca, 2019, v. 28, n. 1, p. 2
- By:
- Publication type:
- Article
Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 2, p. 631, doi. 10.1007/s00415-023-12023-3
- By:
- Publication type:
- Article
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 3, p. 1670, doi. 10.1007/s00415-021-10836-8
- By:
- Publication type:
- Article
Long-term safety and efficacy of daclizumab beta in relapsing–remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 10, p. 2851, doi. 10.1007/s00415-020-09835-y
- By:
- Publication type:
- Article
The clinical and paraclinical correlates of employment status in multiple sclerosis.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 3, p. 1911, doi. 10.1007/s10072-021-05553-z
- By:
- Publication type:
- Article
Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 12, p. 2230, doi. 10.3390/diagnostics11122230
- By:
- Publication type:
- Article
Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 3, p. 464, doi. 10.3390/diagnostics11030464
- By:
- Publication type:
- Article
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864231221331
- By:
- Publication type:
- Article
Multiple Sclerosis and Microbiome.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 3, p. 433, doi. 10.3390/biom12030433
- By:
- Publication type:
- Article
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/1756286420982134
- By:
- Publication type:
- Article
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/1756286420982134
- By:
- Publication type:
- Article
AGGRESSIVE MULTIPLE SCLEROSIS IN THE CONTEXT OF REACHING NEDA AS TREATMENT GOAL.
- Published in:
- Neurologijos Seminarai, 2018, v. 22, n. 3, p. 242
- By:
- Publication type:
- Article
Rehabilitace pacientů, kteří onemocněli covidem-19 (příklad osob s roztroušenou sklerózou).
- Published in:
- Neurologie Pro Praxi, 2022, v. 23, n. 1, p. 84, doi. 10.36290/neu.2022.004
- By:
- Publication type:
- Article
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 7, p. 702, doi. 10.1001/jamaneurol.2023.1184
- By:
- Publication type:
- Article
Association of Pregnancy With the Onset of Clinically Isolated Syndrome.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 12, p. 1496, doi. 10.1001/jamaneurol.2020.3324
- By:
- Publication type:
- Article
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 11, p. 1398, doi. 10.1001/jamaneurol.2020.2453
- By:
- Publication type:
- Article
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies.
- Published in:
- Neurology & Therapy, 2020, v. 9, n. 2, p. 443, doi. 10.1007/s40120-020-00191-7
- By:
- Publication type:
- Article
Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Komentář: Proč bylo třeba vydat nový klinický doporučený postup?
- Published in:
- Remedia, 2024, v. 34, n. 1, p. 51
- By:
- Publication type:
- Article